Brief: Xbrane Biopharma Q3 EBITDA loss at SEK 8.2 mln

Xbrane Biopharma AB

13/11/2017 07:01

Nov 13 (Reuters) - XBRANE BIOPHARMA AB  XBRANE.ST : 
    * Q3 EBITDA LOSS SEK 8.2 MILLION VERSUS LOSS SEK 8.4 
MILLION 
YEAR AGO 
 
Source text for Eikon:  ID:nGNE4Wyhd3  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))